QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO to Present at Cambridge Healthcare Institute’s Seventh Annual Immuno-Oncology Summit
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Co-Founder and CEO RJ Tesi, M.D. will present at the Cambridge Healthcare Institute’s Seventh Annual Immuno-Oncology Summit. The event is taking place in Boston from August 5 through August 9, 2019, and Dr. Tesi’s presentations will include “Targeting Soluble TNF to Improve Efficacy of Combination Immunotherapy,” “Next-Generation Immunotherapies,” and “Targeting ‘Protector’ Cells of the Innate Immune System.” “We are committed to helping treatment-resistant patients by advancing the clinical development of combination therapies and…